Cardiopulmonary function and autologous bone marrow transplantation

Results and predictive value for respiratory failure and mortality

B. Jain, A. A. Floreani, J. R. Anderson, Julie Marie Vose, R. A. Robbins, S. I. Rennard, Joseph Harold Sisson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Cardiopulmonary complications are a major cause of morbidity and mortality in patients undergoing high-dose therapy with stem cell transplant support. Since exercise tolerance testing (ETT) assesses the cardiopulmonary reserve of an individual, we hypothesized that ETT performed prior to transplant would predict respiratory failure and mortality and would be a superior predictor over resting cardiopulmonary function tests. We performed a retrospective study of 191 lymphoma patients who underwent ETT prior to transplant between 1 June 1990 and 31 December 1992 and compared the results of ETT, with resting pulmonary function tests (PFT) and resting cardiac ejection fraction (EF). ETT revealed that cardiac, pulmonary and combined cardiopulmonary limitation were observed in 31, 20 and 16% of the patients, respectively, with a gas diffusion-type limitation being the most common exercise limitation. Resting PFT were abnormal in 58% of patients with a diffusion defect being the most common abnormality. Low EF was observed in 6.8% of patients. Twelve patients eventually required mechanical ventilation post-transplant with only the resting diffusion PFT predictive of this complication. There were five early deaths that were attributable to respiratory failure and neither resting nor ETT studies were predictive of these deaths. ETT and EF performed prior to transplant in lymphoma patients undergoing autologous transplant do not predict for either respiratory failure or short-term mortality. Our findings may be due to the rather low incidence of respiratory failure (6.3%) and low early mortality from cardiopulmonary complications (2.6%) seen in our patient population.

Original languageEnglish (US)
Pages (from-to)561-568
Number of pages8
JournalBone marrow transplantation
Volume17
Issue number4
StatePublished - Apr 1 1996

Fingerprint

Autologous Transplantation
Exercise Tolerance
Bone Marrow Transplantation
Respiratory Insufficiency
Mortality
Respiratory Function Tests
Transplants
Lymphoma
Autografts
Artificial Respiration
Stem Cells
Retrospective Studies
Gases
Exercise
Morbidity
Lung
Incidence

Keywords

  • Bone marrow transplantation
  • Exercise tolerance test
  • Pulmonary function test
  • Pulmonary toxicity
  • Respiratory failure

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Cardiopulmonary function and autologous bone marrow transplantation : Results and predictive value for respiratory failure and mortality. / Jain, B.; Floreani, A. A.; Anderson, J. R.; Vose, Julie Marie; Robbins, R. A.; Rennard, S. I.; Sisson, Joseph Harold.

In: Bone marrow transplantation, Vol. 17, No. 4, 01.04.1996, p. 561-568.

Research output: Contribution to journalArticle

@article{5fa9ddb591414e22827e1862b8623a79,
title = "Cardiopulmonary function and autologous bone marrow transplantation: Results and predictive value for respiratory failure and mortality",
abstract = "Cardiopulmonary complications are a major cause of morbidity and mortality in patients undergoing high-dose therapy with stem cell transplant support. Since exercise tolerance testing (ETT) assesses the cardiopulmonary reserve of an individual, we hypothesized that ETT performed prior to transplant would predict respiratory failure and mortality and would be a superior predictor over resting cardiopulmonary function tests. We performed a retrospective study of 191 lymphoma patients who underwent ETT prior to transplant between 1 June 1990 and 31 December 1992 and compared the results of ETT, with resting pulmonary function tests (PFT) and resting cardiac ejection fraction (EF). ETT revealed that cardiac, pulmonary and combined cardiopulmonary limitation were observed in 31, 20 and 16{\%} of the patients, respectively, with a gas diffusion-type limitation being the most common exercise limitation. Resting PFT were abnormal in 58{\%} of patients with a diffusion defect being the most common abnormality. Low EF was observed in 6.8{\%} of patients. Twelve patients eventually required mechanical ventilation post-transplant with only the resting diffusion PFT predictive of this complication. There were five early deaths that were attributable to respiratory failure and neither resting nor ETT studies were predictive of these deaths. ETT and EF performed prior to transplant in lymphoma patients undergoing autologous transplant do not predict for either respiratory failure or short-term mortality. Our findings may be due to the rather low incidence of respiratory failure (6.3{\%}) and low early mortality from cardiopulmonary complications (2.6{\%}) seen in our patient population.",
keywords = "Bone marrow transplantation, Exercise tolerance test, Pulmonary function test, Pulmonary toxicity, Respiratory failure",
author = "B. Jain and Floreani, {A. A.} and Anderson, {J. R.} and Vose, {Julie Marie} and Robbins, {R. A.} and Rennard, {S. I.} and Sisson, {Joseph Harold}",
year = "1996",
month = "4",
day = "1",
language = "English (US)",
volume = "17",
pages = "561--568",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Cardiopulmonary function and autologous bone marrow transplantation

T2 - Results and predictive value for respiratory failure and mortality

AU - Jain, B.

AU - Floreani, A. A.

AU - Anderson, J. R.

AU - Vose, Julie Marie

AU - Robbins, R. A.

AU - Rennard, S. I.

AU - Sisson, Joseph Harold

PY - 1996/4/1

Y1 - 1996/4/1

N2 - Cardiopulmonary complications are a major cause of morbidity and mortality in patients undergoing high-dose therapy with stem cell transplant support. Since exercise tolerance testing (ETT) assesses the cardiopulmonary reserve of an individual, we hypothesized that ETT performed prior to transplant would predict respiratory failure and mortality and would be a superior predictor over resting cardiopulmonary function tests. We performed a retrospective study of 191 lymphoma patients who underwent ETT prior to transplant between 1 June 1990 and 31 December 1992 and compared the results of ETT, with resting pulmonary function tests (PFT) and resting cardiac ejection fraction (EF). ETT revealed that cardiac, pulmonary and combined cardiopulmonary limitation were observed in 31, 20 and 16% of the patients, respectively, with a gas diffusion-type limitation being the most common exercise limitation. Resting PFT were abnormal in 58% of patients with a diffusion defect being the most common abnormality. Low EF was observed in 6.8% of patients. Twelve patients eventually required mechanical ventilation post-transplant with only the resting diffusion PFT predictive of this complication. There were five early deaths that were attributable to respiratory failure and neither resting nor ETT studies were predictive of these deaths. ETT and EF performed prior to transplant in lymphoma patients undergoing autologous transplant do not predict for either respiratory failure or short-term mortality. Our findings may be due to the rather low incidence of respiratory failure (6.3%) and low early mortality from cardiopulmonary complications (2.6%) seen in our patient population.

AB - Cardiopulmonary complications are a major cause of morbidity and mortality in patients undergoing high-dose therapy with stem cell transplant support. Since exercise tolerance testing (ETT) assesses the cardiopulmonary reserve of an individual, we hypothesized that ETT performed prior to transplant would predict respiratory failure and mortality and would be a superior predictor over resting cardiopulmonary function tests. We performed a retrospective study of 191 lymphoma patients who underwent ETT prior to transplant between 1 June 1990 and 31 December 1992 and compared the results of ETT, with resting pulmonary function tests (PFT) and resting cardiac ejection fraction (EF). ETT revealed that cardiac, pulmonary and combined cardiopulmonary limitation were observed in 31, 20 and 16% of the patients, respectively, with a gas diffusion-type limitation being the most common exercise limitation. Resting PFT were abnormal in 58% of patients with a diffusion defect being the most common abnormality. Low EF was observed in 6.8% of patients. Twelve patients eventually required mechanical ventilation post-transplant with only the resting diffusion PFT predictive of this complication. There were five early deaths that were attributable to respiratory failure and neither resting nor ETT studies were predictive of these deaths. ETT and EF performed prior to transplant in lymphoma patients undergoing autologous transplant do not predict for either respiratory failure or short-term mortality. Our findings may be due to the rather low incidence of respiratory failure (6.3%) and low early mortality from cardiopulmonary complications (2.6%) seen in our patient population.

KW - Bone marrow transplantation

KW - Exercise tolerance test

KW - Pulmonary function test

KW - Pulmonary toxicity

KW - Respiratory failure

UR - http://www.scopus.com/inward/record.url?scp=0029995226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029995226&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 561

EP - 568

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -